Urch Publishing Research Reports

Title	Published	Price
Health Economics in the Drug Life Cycle: Achieving success in drug discovery, development, reimbursement and marketing By: Urch Publishing The increasingly cost-conscious nature of formulary decisions and the willingness of reimbursers to reject a drug for listing on budget impact grounds means that drug companies must address the issue of affordability at a very \| more... Buy by the section \| Search inside this report	1/1/2003	$1,251.00
European Generic Drug Markets - Growth to 2007 By: Urch Publishing The generic drug sector in Europe is poised for significant market growth over the next 5 years. Already generics account for 50% of all prescriptions and this is forecast to reach 75% by 2007. \| more... Buy by the section \| Search inside this report	11/1/2002	$891.00
The Pharmaceutical Pricing and Reimbursement Systems of Central and Eastern Europe By: Urch Publishing In just ten years many Central and East European (CEE) countries have brought their pharmaceuticals industry regulation in line with that of the European Union. Pricing and reimbursement, however, continues to remain a national issue. \| more... Buy by the section \| Search inside this report	6/24/2002	$560.00
Emerging Pharmaceutical Markets - Potential & Problems By: Urch Publishing Drug regulators and representatives of the pharmaceutical industry from the US, Europe and Japan have been participating for nine years in the International Conference on Harmonisation (ICH). The purpose is to eliminate duplicative requirements for \| more... Buy by the section \| Search inside this report	10/26/2001	$351.00
Customer-Driven Pharmaceutical Marketing: developing and exploiting profitable relationships By: Urch Publishing Something is wrong. Traditional strategies and financial machinations are being pursued by pharmaceutical management with decreasingly satisfying results. Mergers and acquisitions are being consummated with only short-term, ad hoc, quick fix results. Traditional schools \| more... Buy by the section \| Search inside this report	3/30/2001	$225.00
Good Laboratory And Good Clinical Practice: Requirements For Compliance - Management Involvement And Cost Implications By: Urch Publishing The advent of the 'Good Practices', Laboratory and Clinical, has had a direct impact on the pharmaceutical and allied industries since 1976. With the arrival of the new directive governing GCP, the implications have become \| more... Search inside this report	3/1/2001	$72.00
Drug Discovery: Current Trends and Future Prospects By: Urch Publishing This report provides a historical review of drug discovery, and descriptions of the various genomic technologies used in drug discovery, such as genotyping and high-throughput screening (HTS). The report explores technologies used for preparing large \| more... Buy by the section \| Search inside this report	2/1/2001	$560.00
New Trends In European Pharmacy By: Urch Publishing Pharmacy - the supply of medicines and related products to the consumer or patient - is undergoing extensive change at the start of the twentieth-first century. At this time the many factors that affect it \| more... Buy by the section \| Search inside this report	1/1/2001	$360.00
A Healthy Business Guide to the Pharmaceutical Industry By: Urch Publishing A jargon-free guide to the industry and its various components. The guide follows the development of a drug from the early R&D stages through to clinical trials, launch, post marketing and product life-cycle. The author \| more... Search inside this report	1/1/2001	$81.00
EU Accession by Central and Eastern European Countries: Issues for Researched-Based Pharmaceutical Companies By: Urch Publishing European Union enlargement to the east brings both threats and opportunities to multinational pharmaceutical companies. This report documents the changes in this sector that will affect all \| more... Buy by the section \| Search inside this report	10/1/2000	$306.00
Trends in the Plastics Industry By: Urch Publishing Highlighting the changes in technological developments, this report reviews all methods of production and processes of monomers like styrene, vinyl chloride, methyl methacrylate and caprolactam and reviews the potential of these materials to reduce the \| more... Search inside this report	10/1/2000	$630.00
The Billion Dollar Pharmaceutical Club: Profiles of the Leading European Players By: Urch Publishing The Billion Dollar Pharmaceutical Club report series provides a unique insight into the leading pharmaceutical manufacturers today. The reports analyse key aspects of the business strategies of over 30 companies and assesses their success by \| more... Search inside this report	9/1/2000	$178.20
The Billion Dollar Pharmaceutical Club: Profiles of the Leading US Players By: Urch Publishing The Billion Dollar Pharmaceutical Club report series provides a unique insight into the leading pharmaceutical manufacturers today. The reports analyse key aspects of the business strategies of over 30 companies and assesses their success by \| more... Search inside this report	8/1/2000	$178.20
The Billion Dollar Pharmaceutical Club: Profiles of the Leading Japanese Players By: Urch Publishing The Billion Dollar Pharmaceutical Club report series provides a unique insight into the leading pharmaceutical manufacturers today. The reports analyse key aspects of the business strategies of over 30 companies and assesses their success by \| more... Search inside this report	8/1/2000	$178.20
Cost Containment in Healthcare: Putting the Pharmaceutical Industry in Perspective By: Urch Publishing This report examines what actions policy-makers, providers and payers have taken to tackle the healthcare problems associtated with an ageing population, rising patient expectations, system inefficiencies, high costs of new drugs and treatments and keeping \| more... Buy by the section \| Search inside this report	8/1/2000	$178.20
China Pharmaceuticals Guide: New Policy and Regulation By: Urch Publishing In a unique collaboration China Concept Consulting, the Chinese Information Centre of The State Drug Administration (SDA) and Informa Pharmaceuticals have prepared the China Pharmaceuticals Guide - a definitive reference manual to the regulation of \| more... Buy by the section \| Search inside this report	6/1/2000	$360.00
WTO and Patents -- The Impact on the Pharmaceutical Industry By: Urch Publishing Comprehensively reviews patent protection and its role within the global pharmaceutical industry. This unique report assess the importance of the TRIPS framework as a step toward globalisation of legal requirements and reviews the role of \| more... Buy by the section \| Search inside this report	5/1/2000	$315.00
Pharmaceutical Regulation in Europe: An Industry Challenge By: Urch Publishing This report provides a thorough analysis of all aspects of pharmaceutical regulation, cutting through complex official documentation to give a clear insight into this complex field. Starting with the very first Community legislation on public \| more... Buy by the section \| Search inside this report	4/1/2000	$270.00
The Future of European Pharmaceutical Distribution By: Urch Publishing This report predicts that on-line ordering by pharmacies will encourage entrepreneurial pharmacists to search for cheaper suppliers thereby pressuring distributors margins and encouraging parallel trade. High amounts of inventory held by pharmaceutical manufacturers is one \| more... Buy by the section \| Search inside this report	4/1/2000	$351.00
Mergers and Acquisitions in the Chemical Industry By: Urch Publishing The high level of activity in chemical industry M&As is set to continue. The value of deals (excluding pharma) rose from $10bn in 1995 to $37bn in 1998 and will approach $50bn in 1999. There \| more... Search inside this report	3/1/2000	$900.00
Global Pharmaceutical Pricing - Strategic Issues and Practical Guidelines By: Urch Publishing If pricing were not already a core issue for pharmaceutical companies, their customers and payers, the introduction of a single European currency will highlight pricing further, as differences between national markets become more transparent. How \| more...	3/1/2000	$358.20
Mergers and Acquisitions in Pharmaceuticals -- Why and How? By: Urch Publishing A step by step reference tool to all aspects of mergers and acquisitions. Illustrating the changes from the early days of high margins and large-scale price premiums for innovative high tech acquisitions through to the \| more... Buy by the section \| Search inside this report	2/1/2000	$270.00
Patient Groups and the Global Pharmaceutical Industry By: Urch Publishing This report gives an overview of the changing dynamics taking place within the pharmaceutical industry world-wide and documents the rise of the patient (consumer) as a potent economic force in healthcare and a prime target \| more... Buy by the section \| Search inside this report	1/1/2000	$360.00
European Medical Devices Directives- A Guide to Beneficial Implementation By: Urch Publishing This report provides insights into the best ways to adopt the medical devices directives for optimum benefit and covers all three directives, plus their changes, in depth, namely: Active Implantable Medical Devices Directive Medical Devices \| more...	8/1/1999	$710.00
Oligonucleotide Players By: Urch Publishing New technological advances in molecular biology have led to the identification of genes associated with major human diseases and to the determination of their genetic basis. Antisense oligonucleotide technology is providing a highly specific strategy \| more... Search inside this report	4/1/1999	$590.00
Title	Published	Price

< prev 1 2 3 next >

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 4